glp-1 users need strength training to prevent muscle loss How Through Exercise GLP-1 Medications and Muscle Loss:

29 Treatment The goals of therapy include the prevention or reversal of hepatic injury and fibrosis

Many telehealth providers frame this as the default because it is easier to stick with

In the case of Ozempic, plaintiffs claim that Novo Nordisk and Eli Lilly were negligent in their responsibility to disclose the risk of severe side effects, thereby endangering the health and well-being of users

SOURCE: American Diabetes Association, news release, June 23, 2025 Copyright 2025 HealthDay

Government Support and Policy Initiatives Recognizing the need for accessible obesity treatments, India plans to offer incentives under the Production Linked Incentive (PLI) scheme to promote the local manufacturing of GLP-1 drugs in 2026